-
Je něco špatně v tomto záznamu ?
Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: A qualitative analysis
SK. Simblett, E. Bruno, S. Siddi, F. Matcham, L. Giuliano, JH. López, A. Biondi, H. Curtis, J. Ferrão, A. Polhemus, M. Zappia, A. Callen, P. Gamble, T. Wykes, RADAR-CNS Consortium,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dospělí MeSH
- epilepsie terapie MeSH
- komunikace * MeSH
- kvalita života MeSH
- lidé středního věku MeSH
- lidé MeSH
- management nemoci MeSH
- mladý dospělý MeSH
- pacientův souhlas se zdravotní péčí * MeSH
- postoj ke zdraví MeSH
- self-management * MeSH
- telemedicína * MeSH
- vztahy mezi lékařem a pacientem * MeSH
- záchvaty MeSH
- zakotvená teorie MeSH
- zapojení pacienta MeSH
- zjišťování skupinových postojů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Itálie MeSH
- Španělsko MeSH
- Spojené království MeSH
BACKGROUND: Innovative uses of mobile health (mHealth) technology for real-time measurement and management of epilepsy may improve the care provided to patients. For instance, seizure detection and quantifying related problems will have an impact on quality of life and improve clinical management for people experiencing frequent and uncontrolled seizures. Engaging patients with mHealth technology is essential, but little is known about patient perspectives on their acceptability. The aim of this study was to conduct an in-depth qualitative analysis of what people with uncontrolled epilepsy think could be the potential uses of mHealth technology and to identify early potential barriers and facilitators to engagement in three European countries. METHOD: Twenty people currently experiencing epileptic seizures took part in five focus groups held across the UK, Italy, and Spain. Participants all completed written consent and a demographic questionnaire prior to the focus group commencing, and each group discussion lasted 60-120 min. A coding frame, developed from a systematic review of the previous literature, was used to structure a thematic analysis. We extracted themes and subthemes from the discussions, focusing first on possible uses of mHealth and then the barriers and facilitators to engagement. RESULTS: Participants were interested in mHealth technology as a clinical detection tool, e.g., to aid communication about seizure occurrence with their doctors. Other suggested uses included being able to predict or prevent seizures, and to improve self-management. Key facilitators to engagement were the ability to raise awareness, plan activities better, and improve safety. Key barriers were the potential for increased stigma and anxiety. Using familiar and customizable products could be important moderators of engagement. CONCLUSION: People with uncontrolled epilepsy think that there is a scope for mHealth technology to be useful in healthcare as a detection or prediction tool. The costs will be compared with the benefits when it comes to engagement, and ongoing work with patients and other stakeholders is needed to design practical resources.
Institute of Psychiatry Psychology and Neuroscience King's College London UK
MSD Czech Republic Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025734
- 003
- CZ-PrNML
- 005
- 20201222155405.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.yebeh.2019.05.035 $2 doi
- 035 __
- $a (PubMed)31247523
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Simblett, Sara K $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK. Electronic address: sara.simblett@kcl.ac.uk.
- 245 10
- $a Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: A qualitative analysis / $c SK. Simblett, E. Bruno, S. Siddi, F. Matcham, L. Giuliano, JH. López, A. Biondi, H. Curtis, J. Ferrão, A. Polhemus, M. Zappia, A. Callen, P. Gamble, T. Wykes, RADAR-CNS Consortium,
- 520 9_
- $a BACKGROUND: Innovative uses of mobile health (mHealth) technology for real-time measurement and management of epilepsy may improve the care provided to patients. For instance, seizure detection and quantifying related problems will have an impact on quality of life and improve clinical management for people experiencing frequent and uncontrolled seizures. Engaging patients with mHealth technology is essential, but little is known about patient perspectives on their acceptability. The aim of this study was to conduct an in-depth qualitative analysis of what people with uncontrolled epilepsy think could be the potential uses of mHealth technology and to identify early potential barriers and facilitators to engagement in three European countries. METHOD: Twenty people currently experiencing epileptic seizures took part in five focus groups held across the UK, Italy, and Spain. Participants all completed written consent and a demographic questionnaire prior to the focus group commencing, and each group discussion lasted 60-120 min. A coding frame, developed from a systematic review of the previous literature, was used to structure a thematic analysis. We extracted themes and subthemes from the discussions, focusing first on possible uses of mHealth and then the barriers and facilitators to engagement. RESULTS: Participants were interested in mHealth technology as a clinical detection tool, e.g., to aid communication about seizure occurrence with their doctors. Other suggested uses included being able to predict or prevent seizures, and to improve self-management. Key facilitators to engagement were the ability to raise awareness, plan activities better, and improve safety. Key barriers were the potential for increased stigma and anxiety. Using familiar and customizable products could be important moderators of engagement. CONCLUSION: People with uncontrolled epilepsy think that there is a scope for mHealth technology to be useful in healthcare as a detection or prediction tool. The costs will be compared with the benefits when it comes to engagement, and ongoing work with patients and other stakeholders is needed to design practical resources.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a postoj ke zdraví $7 D001294
- 650 12
- $a komunikace $7 D003142
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a epilepsie $x terapie $7 D004827
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zjišťování skupinových postojů $7 D017144
- 650 _2
- $a zakotvená teorie $7 D066296
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a pacientův souhlas se zdravotní péčí $7 D010342
- 650 _2
- $a zapojení pacienta $7 D010358
- 650 12
- $a vztahy mezi lékařem a pacientem $7 D010817
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a záchvaty $7 D012640
- 650 12
- $a self-management $7 D000073278
- 650 12
- $a telemedicína $7 D017216
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Itálie $7 D007558
- 651 _2
- $a Španělsko $7 D013030
- 651 _2
- $a Spojené království $7 D006113
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bruno, Elisa $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
- 700 1_
- $a Siddi, Sara $u Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Centro de Investigació Biomedica en Red CIBERSAM, Spain; University of Barcelona, Barcelona, Spain.
- 700 1_
- $a Matcham, Faith $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
- 700 1_
- $a Giuliano, Loretta $u Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Section of Neurosciences, University of Catania, Catania, Italy.
- 700 1_
- $a López, Jorge Hortas $u QITERIA Investigación Social Aplicada, Madrid, Spain.
- 700 1_
- $a Biondi, Andrea $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
- 700 1_
- $a Curtis, Hannah $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
- 700 1_
- $a Ferrão, José $u MSD Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Polhemus, Ashley $u MSD Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Zappia, Mario $u Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Section of Neurosciences, University of Catania, Catania, Italy.
- 700 1_
- $a Callen, Antonio $u Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Centro de Investigació Biomedica en Red CIBERSAM, Spain; University of Barcelona, Barcelona, Spain.
- 700 1_
- $a Gamble, Peter $u MSD Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Wykes, Til $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust, King's College London, UK.
- 710 2_
- $a RADAR-CNS Consortium
- 773 0_
- $w MED00005701 $t Epilepsy & behavior : E&B $x 1525-5069 $g Roč. 97, č. - (2019), s. 123-129
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31247523 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155401 $b ABA008
- 999 __
- $a ok $b bmc $g 1599879 $s 1116420
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 97 $c - $d 123-129 $e 20190624 $i 1525-5069 $m Epilepsy & behavior $n Epilepsy Behav $x MED00005701
- LZP __
- $a Pubmed-20201125